Found 12 matching trials
Ritlecitinib for Cicatricial Alopecia PHASE2 Alopecia could be subdivided into two main groups of diseases: non-scarring...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults PHASE1 The purpose of this study is to compare if three forms of study medicine (c...
Show More Location
Pfizer Clinical Research Unit - Brussels
Learn More & Join Trial
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata PHASE3 The purpose of the study is to learn about the safety and effects of the st...
Show More Location
The Kirklin Clinic of UAB Hospital (Radiology)
Learn More & Join Trial
Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants PHASE1 This will be a Phase 1, 2 period, fixed sequence, multiple-dose, open-label...
Show More Location
New Haven Clinical Research Unit
Learn More & Join Trial
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE PHASE2 Dual objectives of increased efficacy compared to currently available SoC R...
Show More Location
,,UMHAT - Georgi Stranski" EAD
Learn More & Join Trial
A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata PHASE3 The purpose of this clinical study is to learn about the safety and effects...
Show More Location
California Dermatology & Clinical Research Institute
Learn More & Join Trial
Ritlecitinib in CTCL PHASE2 The purpose of this research study is to evaluate the effectiveness and saf...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. PHASE2 The purpose of the study is to learn about the safety and effects of the st...
Show More Location
Saguaro Dermatology - Phoenix
Learn More & Join Trial
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo PHASE3 This study is to evaluate how safe and effective ritlecitinib is in partici...
Show More Status
Active Not Recruiting
Location
California Dermatology & Clinical Research Institute
Learn More & Join Trial
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D) PHASE2 A multi-center, placebo-controlled, double blind, 1:1:1 randomized control ...
Show More Status
Active Not Recruiting
Location
Children's Hospital Orange County
Learn More & Join Trial